FDA Approved: IBANDRONATE SODIUM — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved the original application for ibandronate sodium (generic) by Apotex Corp., enabling generic access to the osteoporosis treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• IBANDRONATE SODIUM (ibandronate sodium)

Snippet

ORIG AP for IBANDRONATE SODIUM (IBANDRONATE SODIUM)